Ignite Creation Date:
2025-12-26 @ 11:47 AM
Ignite Modification Date:
2026-04-15 @ 10:15 PM
Study NCT ID:
NCT01221116
Status:
TERMINATED
Last Update Posted:
2010-11-02
First Post:
2010-10-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
Sponsor:
Ullevaal University Hospital
Organization:
Study Overview
Official Title:
Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
Status:
TERMINATED
Status Verified Date:
2003-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The study was stopped due to difficulties in including patients
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hypothesis: Treatment with levosimendan will preserve myocardial function and hemodynamics after cardiac surgery and lead to reduced stay at intensive care unit
Detailed Description:
Single center, prospective, randomized parallel-group, double-blinded study
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: